Skip to main content
Caplight Logo









Resyca BV

Resyca BV

Private
EnschedeHealthcare & Life Scienceshttps://resyca.com

Last Round

Corporate Funding

Nov 17, 2020

Est. Valuation

$35.29M

Total Funding Raised

$18M

Company Overview

Resyca BV operates in Healthcare & Life Sciences and is based in Enschede. Its latest recorded funding round was a Corporate Funding round in November 2020.

Resyca BV is a healthcare technology company that specializes in the development and manufacturing of soft mist inhalation and nasal spray devices for pharmaceutical and biotech applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Resyca BV Comparables

Compare Resyca BV with similar companies based on industry and business-model similarity.

Resyca BV comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medspray B.V.
85%
Merxin Ltd
80%
Suzhou Singmed Medical Device Science and Technology Ltd.
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Resyca BV Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingNov 17, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Deborah Jones

Chief Executive Officer

Executive Team

Bernhard Müllinger

Chief Operating Officer

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 11, 2026

    Grew 33% QoQ from 9 to 12 employees.

  • Jan 25, 2025

    Monthly visitors grew 108% MoM, reaching 1.8K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Resyca BV Filings

Explore SEC and related filing metadata, where available.

Resyca BV filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Resyca BV's valuation, stock price, and market status.

Is Resyca BV a public or private company?

Resyca BV is a private company.

What is the current stock price of Resyca BV?

Resyca BV is a private company, so its shares have no public market price. Caplight tracks Resyca BV's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Resyca BV worth (valuation)?

Resyca BV's valuation is estimated at $35.3M based on funding round data.

Can I buy Resyca BV stock?

Resyca BV shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Resyca BV's last funding round?

Resyca BV's most recent funding round was Corporate Funding on November 17, 2020.

Who are the main investors in Resyca BV?

Investor information for Resyca BV is not publicly disclosed.

Will Resyca BV IPO soon?

No public IPO plans have been announced for Resyca BV.

How can I track Resyca BV secondary market activity?

Caplight tracks bids, offers, and trades in Resyca BV's shares on secondary markets.

Firmographic Details

HeadquartersEnschede
Employee Range14
Year Founded2020
Last FundingNov 17, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?